发明名称 CANCER STEM CELL ISOLATION
摘要 The present invention addresses the problem of providing: substantially uniform cancer stem cell populations containing cancer stem cells isolated using cell markers; and a method for producing said cancer stem cell populations. The present invention further addresses the problem of providing: a method for isolating cancel stem cells having a high proliferative capacity and cancer stem cells having a low proliferative capacity; a method for deriving stem cells having a different proliferative capacity; and cancer stem cells isolated/derived by such methods for isolation/derivation. The present invention also addresses the problem of providing: a drug screening method using the aforementioned cancer stem cells or cancer stem cell populations; and a method for detecting/identifying or quantifying the presence of the aforementioned cancer stem cells or cancer stem cell populations. Thus enabled is the acquisition of high-purity colon cancer stem cells (CSC) in large volumes, and the identification of two types of colon CSC state, distinguished by the expression of Lgr5.
申请公布号 WO2013035824(A1) 申请公布日期 2013.03.14
申请号 WO2012JP72852 申请日期 2012.09.07
申请人 PHARMALOGICALS RESEARCH PTE. LTD.;CHUGAI SEIYAKU KABUSHIKI KAISHA;YAMAZAKI, TATSUMI;OKABE, HISAFUMI;KOBAYASHI, SHINTA;WATANABE, TAKESHI;MATSUBARA, KOICHI;KATO, ATSUHIKO;SUZUKI, MASAMI 发明人 YAMAZAKI, TATSUMI;OKABE, HISAFUMI;KOBAYASHI, SHINTA;WATANABE, TAKESHI;MATSUBARA, KOICHI;KATO, ATSUHIKO;SUZUKI, MASAMI
分类号 C12N5/095;A61K31/4745;A61K31/513;A61K31/7088;A61K39/395;A61K48/00;A61P35/00;A61P35/02;A61P35/04;C07K16/30;C12N15/09;C12N15/113;C12Q1/02;C12Q1/04;G01N33/15;G01N33/53;G01N33/574 主分类号 C12N5/095
代理机构 代理人
主权项
地址